0
What else can I help you with?
Can Crohns Disease turn to Cancer?
Yes. Some studies have shown as much as a five times increased risk in the development of intestinal cancer in patients with Crohns disease as compared to the general population. This should not make you panic however. More than 90% of IBD patients never develop cancers and because of the increased testing done on bowel disease patients those who do develop cancers are almost always caught early and survival rates are better than those who are not diagnosed as early.
How often should at risk patients be screened for colorectal cancer?
Many doctors screen such patients more often than every three to five years. Those with ulcerative colitis should be screened beginning 10 years after the onset of disease; those with Crohn's colitis beginning 15 years after the onset of disease.
What are some emotional effects on cancer patients?
Cancer often makes people afraid because of all of the stories they hear about cancer- the awful treatments, and that it's incurable. (Most forms of cancer are at least sometimes curable.) Also, it makes people feel inadequate because it's a disease that came out of themselves, and not from a microbe or virus.
What nonifectiowhat nonifectious disease is often caused bya mutagen?
cancer
What is susceptible individual who can harbor the disease called?
A susceptible individual who can harbor the disease is often referred to as a "host." This individual provides an environment for the pathogen to thrive and potentially cause illness. Host factors such as age, immune status, and genetics can influence the likelihood of becoming infected.
What gender can get breast cancer?
Both female and male are susceptible to breast cancer .@this person ^^^ females are much more vulnerable to this cancer though...
What is an antigen tumor marker that is often elevated in patients with colon cancer?
carcinoembryonic antigen (CEA)
How are severe burn patients fed?
Tube feeding is often used to provide nutrients to patients who have suffered burns or who have inflammatory bowel disease.
What disease is labeled the silent killer?
Not a disease per say, the overconsumption of salt is often called the "silent killer".
What are the survival rates for thyroid cancer?
Thyroid cancer is generally associated with very high survival rates. The prognosis for thyroid cancer is often favorable, with the majority of patients surviving the disease. Survival rates can vary depending on the specific type and stage of thyroid cancer. Here are some general survival rate statistics: Papillary Thyroid Cancer: Papillary thyroid cancer, the most common type, has a high survival rate. The 5-year relative survival rate for localized papillary thyroid cancer is approximately 99%, meaning that almost all patients with localized disease are alive 5 years after diagnosis. Even for regional (spread to nearby lymph nodes) or distant (metastatic) disease, the 5-year survival rate remains relatively high at around 93%. Follicular Thyroid Cancer: Follicular thyroid cancer also has favorable survival rates. The 5-year relative survival rate for localized disease is approximately 97%. For regional disease, it's about 86%, and for distant disease, it's around 67%. Medullary Thyroid Cancer: Medullary thyroid cancer has slightly lower survival rates compared to papillary and follicular types. For localized disease, the 5-year relative survival rate is around 98%. For regional disease, it's about 89%, and for distant disease, it drops to approximately 41%. Anaplastic Thyroid Cancer: Anaplastic thyroid cancer is the most aggressive form of thyroid cancer, and survival rates are much lower. The 5-year relative survival rate for this type is generally less than 10%, and many cases are fatal.
Does cancer exist or is it just a major cover up?
Cancer,most certainly exists. It is the name given to a serious disease, often fatal.
More and more patients are surviving today from kidney cancer?
There were over 1.3 million new cancers diagnosed in the United States just last year and over 50,000 of these patients were diagnosed with kidney cancer. There is hope; more than 200,000 survivors of kidney cancer are still living today in the United States. Advances in surgical procedures, diagnosis and treatment options are allowing more patients to live with this disease and continue to live their normal lifestyles and schedules. With the Food and Drug Administration’s recent approval of new medications to treat this advanced disease, today marks a new beginning for kidney cancer patients. These drugs work by targeting cancer cells in ways different than current drugs and will have a more positive impact for those who are suffering. Continuing research is improving the understanding of kidney disease and increasing the options that patients have to fight it. Often times, kidney cancer is referred to by its medical name, renal cell carcinoma. Renal is taken from the Latin word renalis meaning kidney. Cancer of the kidneys includes different forms, including papillary, clear cell, transitional cell, sarcomatoid and others. It usually causes symptoms or signs in its early stages. In later stages, symptoms often times include, back pain, weight loss, blood in the urine, fatigue and intermittent fever. There are some kidney cancer patients who are diagnosed before it has spread to other areas of the body, while there are others who have metastatic disease when the cancer is first diagnosed. Surgery is sometimes the first type of treatment, but often systemic treatment (treatment that is swallowed or injected) may be a recommendation before any surgery, though it is rare. If surgery is chosen as the first type of treatment, an additional type may be needed to delay the cancer from returning or to treat metastatic disease. As for proper treatment options for kidney cancer, it is be determined by the patient and his or her treatment team. The best approach may depend on many different factors, including the kind of cancer present, the general health of the patient, whether or not the cancer has spread and the preference of the patient.
